We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Advanced Melanoma

Journal Scan / Research · December 02, 2020

Molecular and Immunological Associations of Elevated Serum LDH in Metastatic Melanoma Patients

Cancer Medicine


Additional Info

Cancer Medicine
Molecular and Immunological Associations of Elevated Serum Lactate Dehydrogenase in Metastatic Melanoma Patients: A Fresh Look at an Old Biomarker
Cancer Med 2020 Nov 01;9(22)8650-8661, GM Fischer, FCL Carapeto, AY Joon, LE Haydu, H Chen, F Wang, JS Van Arnam, JL McQuade, K Wani, JM Kirkwood, JF Thompson, MT Tetzlaff, AJ Lazar, HA Tawbi, JE Gershenwald, RA Scolyer, GV Long, MA Davies

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading